(Q24202243)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740606%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

meta-analysis

0 references

title

Creatine for treating muscle disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740606%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Rudolf A Kley

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740606%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Mark A Tarnopolsky

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740606%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Matthias Vorgerd

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740606%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

5 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740606%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740606%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740606%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

CD004760

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740606%20AND%20SRC:MED&resulttype=core&format=json

Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study.

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

A placebo-controlled crossover trial of creatine in mitochondrial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Beneficial effects of creatine supplementation in dystrophic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine monohydrate in DM2/PROMM: a double-blind placebo-controlled clinical study. Proximal myotonic myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine monohydrate in myotonic dystrophy: a double-blind, placebo-controlled clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Effects of oral creatine supplementation in a patient with MELAS phenotype and associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Effects of resistance exercise and creatine supplementation on myasthenia gravis: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine monohydrate increases strength in patients with neuromuscular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Attenuation of free radical production and paracrystalline inclusions by creatine supplementation in a patient with a novel cytochrome b mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Effect of Creatine and Weight Training on Muscle Creatine and Performance in Vegetarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Resistance training exercise and creatine in patients with Charcot-Marie-Tooth disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Effect of creatine ingestion after exercise on muscle thickness in males and females

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine supplementation combined with resistance training in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Effects of resistance exercise with and without creatine supplementation on gene expression and cell signaling in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine supplementation during college football training does not increase the incidence of cramping or injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Few adverse effects of long-term creatine supplementation in a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Exploring the therapeutic role of creatine supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Muscle creatine loading in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Glucocorticoid corticosteroids for Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Phosphorus magnetic resonance spectroscopy of brain in mitochondrial cytopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Single- and multiple-dose pharmacokinetics of oral creatine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Long-term oral creatine supplementation does not impair renal function in healthy athletes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Adverse effects of creatine supplementation: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Effect of oral creatine supplementation on urinary methylamine, formaldehyde, and formate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Drug treatment for facioscapulohumeral muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Global and targeted gene expression and protein content in skeletal muscle of young men following short-term creatine monohydrate supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Risk assessment for creatine monohydrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

A clinical trial of creatine in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine transporter and mitochondrial creatine kinase protein content in myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

American College of Sports Medicine roundtable. The physiological and health effects of oral creatine supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine supplementation in Huntington's disease: a placebo-controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine and creatinine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine for treating muscle disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine for treating muscle disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine for treating muscle disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB4

Dietary supplement creatine protects against traumatic brain injury

21 January 2018

1 reference

12 December 2020

Supplementation with creatine monohydrate in children with mitochondrial encephalomyopathies

1 reference

12 December 2020

Cloning and sequencing of rat kidney L-arginine:glycine amidinotransferase. Studies on the mechanism of regulation by growth hormone and creatine

1 reference

12 December 2020

Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults

1 reference

12 December 2020

Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis

1 reference

12 December 2020

Phosphocreatinine in myotonic dystrophy (Steinert's disease)

1 reference

12 December 2020

Trial therapy of acute polymyositis with phosphocreatine

1 reference

12 December 2020

Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin

1 reference

12 December 2020

Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.

1 reference

12 December 2020

Creatine treatment in MELAS

1 reference

12 December 2020

A Na(+)-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression

1 reference

12 December 2020

Acute creatine loading increases fat-free mass, but does not affect blood pressure, plasma creatinine, or CK activity in men and women

1 reference

12 December 2020

Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease

1 reference

12 December 2020

A functional index in myositis.

1 reference

12 December 2020

Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans.

1 reference

12 December 2020

Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy

1 reference

12 December 2020

Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

Increase of total creatine in human brain after oral supplementation of creatine-monohydrate.

1 reference

12 December 2020

Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study

1 reference

12 December 2020

Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease.

1 reference

12 December 2020

[Dermatomyositis with cardiac involvment and trial treatment with phosphocreatine]

1 reference

12 December 2020

A clinical trial of creatine monohydrate in muscular dystrophy patients

1 reference

12 December 2020

Neuroprotective effects of creatine administration against NMDA and malonate toxicity

1 reference

12 December 2020

Long-term creatine supplementation does not significantly affect clinical markers of health in athletes

1 reference

12 December 2020

A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies

1 reference

12 December 2020

Effects of repeated creatine supplementation on muscle, plasma, and urine creatine levels

1 reference

12 December 2020

In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease

1 reference

12 December 2020

The therapeutic potential of oral creatine supplementation in muscle disease

1 reference

12 December 2020

Creatine monohydrate and resistance training increase bone mineral content and density in older men.

1 reference

12 December 2020

Creatine monohydrate supplementation enhances high-intensity exercise performance in males and females

1 reference

12 December 2020

Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study

1 reference

12 December 2020

Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial

1 reference

12 December 2020

10.1002/14651858.CD004760.PUB4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740606%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740606%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

PubMed publication ID

23740606

1 reference